345 related articles for article (PubMed ID: 34189985)
21. The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.
Roseman L; Leech R; Feilding A; Nutt DJ; Carhart-Harris RL
Front Hum Neurosci; 2014; 8():204. PubMed ID: 24904346
[TBL] [Abstract][Full Text] [Related]
22. Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.
Preller KH; Duerler P; Burt JB; Ji JL; Adkinson B; Stämpfli P; Seifritz E; Repovš G; Krystal JH; Murray JD; Anticevic A; Vollenweider FX
Biol Psychiatry; 2020 Jul; 88(2):197-207. PubMed ID: 32111343
[TBL] [Abstract][Full Text] [Related]
23. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.
Carhart-Harris RL; Roseman L; Bolstridge M; Demetriou L; Pannekoek JN; Wall MB; Tanner M; Kaelen M; McGonigle J; Murphy K; Leech R; Curran HV; Nutt DJ
Sci Rep; 2017 Oct; 7(1):13187. PubMed ID: 29030624
[TBL] [Abstract][Full Text] [Related]
24. Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.
Lord LD; Expert P; Atasoy S; Roseman L; Rapuano K; Lambiotte R; Nutt DJ; Deco G; Carhart-Harris RL; Kringelbach ML; Cabral J
Neuroimage; 2019 Oct; 199():127-142. PubMed ID: 31132450
[TBL] [Abstract][Full Text] [Related]
25. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
[TBL] [Abstract][Full Text] [Related]
26. Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.
McCulloch DE; Knudsen GM; Barrett FS; Doss MK; Carhart-Harris RL; Rosas FE; Deco G; Kringelbach ML; Preller KH; Ramaekers JG; Mason NL; Müller F; Fisher PM
Neurosci Biobehav Rev; 2022 Jul; 138():104689. PubMed ID: 35588933
[TBL] [Abstract][Full Text] [Related]
27. High dose psilocybin is associated with positive subjective effects in healthy volunteers.
Nicholas CR; Henriquez KM; Gassman MC; Cooper KM; Muller D; Hetzel S; Brown RT; Cozzi NV; Thomas C; Hutson PR
J Psychopharmacol; 2018 Jul; 32(7):770-778. PubMed ID: 29945469
[TBL] [Abstract][Full Text] [Related]
28. Mindfulness-based intervention to decrease mood lability in at-risk youth: Preliminary evidence for changes in resting state functional connectivity.
Hafeman DM; Ostroff AN; Feldman J; Hickey MB; Phillips ML; Creswell D; Birmaher B; Goldstein TR
J Affect Disord; 2020 Nov; 276():23-29. PubMed ID: 32697703
[TBL] [Abstract][Full Text] [Related]
29. Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice.
Grandjean J; Buehlmann D; Buerge M; Sigrist H; Seifritz E; Vollenweider FX; Pryce CR; Rudin M
Neuroimage; 2021 Jan; 225():117456. PubMed ID: 33069863
[TBL] [Abstract][Full Text] [Related]
30. Functional and structural connectivity of the executive control network in college binge drinkers.
Sousa SS; Sampaio A; Marques P; López-Caneda E; Gonçalves ÓF; Crego A
Addict Behav; 2019 Dec; 99():106009. PubMed ID: 31487578
[TBL] [Abstract][Full Text] [Related]
31. Cerebellar Neural Circuits Involving Executive Control Network Predict Response to Group Cognitive Behavior Therapy in Social Anxiety Disorder.
MinlanYuan ; Meng Y; Zhang Y; Nie X; Ren Z; Zhu H; Li Y; Lui S; Gong Q; Qiu C; Zhang W
Cerebellum; 2017 Jun; 16(3):673-682. PubMed ID: 28155138
[TBL] [Abstract][Full Text] [Related]
32. Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats.
Reinwald JR; Schmitz CN; Skorodumov I; Kuchar M; Weber-Fahr W; Spanagel R; Meinhardt MW
Transl Psychiatry; 2023 Dec; 13(1):392. PubMed ID: 38097569
[TBL] [Abstract][Full Text] [Related]
33. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
Gukasyan N; Davis AK; Barrett FS; Cosimano MP; Sepeda ND; Johnson MW; Griffiths RR
J Psychopharmacol; 2022 Feb; 36(2):151-158. PubMed ID: 35166158
[TBL] [Abstract][Full Text] [Related]
35. Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.
Grimm O; Kraehenmann R; Preller KH; Seifritz E; Vollenweider FX
Eur Neuropsychopharmacol; 2018 Jun; 28(6):691-700. PubMed ID: 29703645
[TBL] [Abstract][Full Text] [Related]
36. Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.
Gaddis A; Lidstone DE; Nebel MB; Griffiths RR; Mostofsky SH; Mejia AF; Barrett FS
Neuroimage; 2022 Oct; 260():119434. PubMed ID: 35792293
[TBL] [Abstract][Full Text] [Related]
37. Effects of a single dose of psilocybin on behaviour, brain 5-HT
Donovan LL; Johansen JV; Ros NF; Jaberi E; Linnet K; Johansen SS; Ozenne B; Issazadeh-Navikas S; Hansen HD; Knudsen GM
Eur Neuropsychopharmacol; 2021 Jan; 42():1-11. PubMed ID: 33288378
[TBL] [Abstract][Full Text] [Related]
38. Resting state connectivity predictors of symptom change during gaze-contingent music reward therapy of social anxiety disorder.
Zhu X; Lazarov A; Dolan S; Bar-Haim Y; Dillon DG; Pizzagalli DA; Schneier F
Psychol Med; 2023 May; 53(7):3115-3123. PubMed ID: 35314008
[TBL] [Abstract][Full Text] [Related]
39. Broadband cortical desynchronization underlies the human psychedelic state.
Muthukumaraswamy SD; Carhart-Harris RL; Moran RJ; Brookes MJ; Williams TM; Errtizoe D; Sessa B; Papadopoulos A; Bolstridge M; Singh KD; Feilding A; Friston KJ; Nutt DJ
J Neurosci; 2013 Sep; 33(38):15171-83. PubMed ID: 24048847
[TBL] [Abstract][Full Text] [Related]
40. The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.
Rucker JJ; Marwood L; Ajantaival RJ; Bird C; Eriksson H; Harrison J; Lennard-Jones M; Mistry S; Saldarini F; Stansfield S; Tai SJ; Williams S; Weston N; Malievskaia E; Young AH
J Psychopharmacol; 2022 Jan; 36(1):114-125. PubMed ID: 35090363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
